(Q36873318)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Flow cytometric characterization and clinical outcome of CD4+ T-cell lymphoma in dogs: 67 cases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

P R Avery

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

J L Bromberek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

D M Seelig

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

R Elmslie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

S Correa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

E J Ehrhart

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

P S Morley

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

A C Avery

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

3 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

Journal of Veterinary Internal Medicine

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

538-546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

Molecular profiling reveals prognostically significant subtypes of canine lymphoma

7 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Classification of canine malignant lymphomas according to the World Health Organization criteria.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Immunophenotypic characterization of canine lymphoproliferative disorders

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Asparaginase and MOPP treatment of dogs with lymphoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Clinical, histopathological and immunohistochemical characterization of canine indolent lymphoma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

T-cell-derived malignant lymphoma in the boxer breed.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma and acute biphenotypic leukemias.

4 September 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

4 September 2018

https://api.crossref.org/works/10.1111%2FJVIM.12304

Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Class II antigens on canine T lymphocytes

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857986

Adult T-Cell Leukemia/Lymphoma in Bahia, Brazil

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJVIM.12304

Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas

21 January 2018

1 reference

12 December 2020

Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis

1 reference

12 December 2020

Response rate after administration of a single dose of doxorubicin in dogs with B-cell or T-cell lymphoma: 41 cases (2006-2008)

1 reference

12 December 2020

Canine indolent nodular lymphoma

1 reference

12 December 2020

Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry

1 reference

12 December 2020

Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma

1 reference

12 December 2020

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

1 reference

12 December 2020

Immunophenotypic and cytomorphologic subclassification of T-cell lymphoma in the boxer breed

1 reference

12 December 2020

Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III

1 reference

12 December 2020

HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen

1 reference

12 December 2020

Identifiers

DOI

10.1111/JVIM.12304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495161%20AND%20SRC:MED&resulttype=core&format=json